EGFR and allergic asthma: In HDM-induced allergic asthma mouse models, oxidative EGFR activation was diminished by treatment with DUOX1 inhibitor with improvement of airway inflammation including neutrophilic airway inflammation and Th2 cytokine production and mucus metaplasia [48].